Neuroleptic malignant syndrome associated with clozapine may be atypical and tend not to be characterized by rigidity, fevers, and elevation of creatine phosphokinase that are seen with standard antipsychotic drugs. Rather, the presentation in clozapine-treated patients may include delirium, autonomic instability, and milder extrapyramidal symptoms (Hasan and Buckley, 1998; Karagianis et al., 1999).
Ref:-
Hasan, S. & Buckley, P. (1998) Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. American Journal of Psychiatry, 155, 1113-1116.
Karagianis, J.L., Philips, L.C., Hogan, K.P., et al. (1999) Clozapine-associated neuroleptic syndrome: two new cases and a review of the literature. Annals of Pharmacotherapy, 33, 623-630.
No Pingbacks for this post yet...
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 | |
This blog on Clinical Psychopharmacology is maintained by Dr. Shahul Ameen, M.D., Psychiatrist, St. John's Hospital, Kattappana, Idukki, Kerala, India.
Psychopharmacology Tips is a part of PsyPlexus, a portal for mental health professionals.
This blog is only for educational purpose of psychiatrists and other physicians. The information published in this blog is not intended for use as a substitute for consultation to a licensed health professional. Patients and consumers who visit Psychopharmacology Tips should carefully review the information gathered from the site with a professional healthcare provider.